Miulli General Hospital
12
2
4
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
High Intensity His Bundle Pacing in Heart Failure Patients With Narrow QRS Outcome Study
Role: lead
Incremental Haemodialysis in Incident Patients
Role: collaborator
Clinical-ultrasonographic Assessment of Pulmonary Emphysema
Role: collaborator
Artificial Intelligence and Hepatocellular Carcinoma
Role: collaborator
Radiotherapy and Atrial Fibrillation
Role: lead
Empagliflozin and Atrial Fibrillation Treatment
Role: lead
A Novel Approach to Posterior Mesh Fixation in Laparoscopic Sacral Colpopexy
Role: collaborator
Different Types of Suture for Sacral Colpopexy
Role: collaborator
Laparoscopic Sacrocolpopexy Versus POPS in the Management of Pelvic Prolapse
Role: collaborator
Probing the Dry Weight by Bioimpedance: The Resistance Stabilization Test
Role: lead
Probing the Dry Weight (DW) by Bioimpedance (BIA): Which is the Gold Standard Between Clinical DW and BIA DW?
Role: lead
Calcium Concentration in Bicarbonate Hemodialysis (HD)
Role: lead
All 12 trials loaded